SANVIN group

The company has 3 business units. The group has a presence in key API & intermediate manufacturing such as cardiovascular, Pain Management, Anaesthetics, and Deaddition among others.In 16 years, the group today has evolved into a knowledge driven company manufacturing active pharmaceutical ingredients. It is R&D focused and has a multi - product portfolio with manufacturing facilities and exports in several countries.Our group exports across the globe with more than 80% of its revenue derived out of international operations. Our customers include premium multi-national companies. We have multiple facilities approved by leading regulatory agencies such as TGA-AUSTRALIA, COFEPRIS MEXICO, WHO-GENEVA, JAPANESE accreditation, and are also approved by many of our esteemed international customers.